Atsushi Yoshida
7PUBLICATIONS
6CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (7)
Sort by Publication Date:
|Apr 13, 2025
Reply to the letter to the editor "Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients".Takeshi Ushigusa, Atsushi Yoshida, Naoki Kanomata
|Mar 17, 2025
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study.Takeshi Ushigusa, Nami Hirakawa, Yuka Kajiura
|Dec 27, 2024
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study.Takeshi Ushigusa, Nami Hirakawa, Yuka Kajiura
|Jan 03, 2023
Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis.Tomohiro Ochi, Atsushi Yoshida, Osamu Takahashi
Pageof 2